GE Healthcare Life Sciences
Biacore Life Sciences
You are here: Biacore Life Sciences > Product Range > Systems Overview > Biacore X100 > Case Studies > Uppsala University
Uppsala UniversityMercodia AB
printer friendly

Putting Biacore X100 to the test

Biacore X100 is designed to enable new users to run successful assays from day one. PhD student and protein interaction analysis novice, Thuy Tran, put this theory to the test.
Research goal:
Compare binding of several Affibody® molecules to HER2

Determine binding specificity, affinity and on/off rates

Specificity of Affibody molecules rapidly defined
Thuy rapidly demonstrated binding specificity for all Affibody molecules

Compared binding levels to immobilized HER2 and a reference protein

Affibodies (Affibody AB, Sweden) are small highly target-specific binding proteins (7 kDa). HER2 is an EGFR familiy member, and is the therapeutic target of the anti-breast cancer humanized mAb, Herceptin
Enlarge
Straightforward analysis of  high affinity binders using single cycle kinetics

Standard kinetic assays analyze a different concentration of sample  in successive cycles and any remaining bound sample must be completely removed by regeneration of the surface

Good regeneration conditions could not be found for the very high affinity variants, but Thuy used regeneration-free, single-cycle kinetics to easily and quickly acquire the data 

Enlarge